Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients
Clinical trial NCT01001832 · COMPLETED
Trial details
- NCT number
- NCT01001832
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-02-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.